Protagonist Therapeutics Statistics
NASDAQ: PTGXHealth CareBiotechnology: Pharmaceutical PreparationsUSD
139.91-1.01 (-0.72%)
At close: Oct 8, 4:00 PM ET · Delayed 15 min
Protagonist Therapeutics by the numbers
Protagonist Therapeutics has a market capitalization of $9.05 billion based on 64.71M shares outstanding. Its trailing P/E ratio is 135.8, above the 3-company peer median of 27.7. The stock trades 3.7% below its 50-day average and 24.6% above its 200-day average.
Average daily trading volume is 623.06K shares, or about $87.2 million in dollar volume.
Summary generated from market data by MetaCap's automated system. Methodology
PTGX valuation vs. peer median
Valuation
- Market cap
- $9.05B
- P/E (TTM)
- 135.83
- Price / sales (latest FY)
- 196.74
- EPS (TTM)
- $1.03
- Shares outstanding
- 64.71M
Price and trading
- Previous close
- 140.92
- Open
- 139.57
- Day range
- 137.99 – 142.18
- 52-week range
- 65.75 – 160.81
- 52-week change
- +114.26%
- 50-day moving average
- 145.35
- 200-day moving average
- 112.27
- Beta
- —
- Volume
- 1.00M
- Average volume
- 623.06K
Dividends and events
- Annual dividend
- None
- Next earnings date
- Nov 5, 2026
Additional statistics
- Market Cap
- 9.05B
- Pe
- 135.83
- Forward Pe
- -702.54
- Eps
- 1.03
- Dividend Yield
- 0.00%
- Dividend Rate
- 0.00
- Week52 High
- 160.81
- Week52 Low
- 65.75
- Avg Volume
- 623.06K
- Shares Outstanding
- 64.71M
- Ma50
- 145.35
- Ma200
- 112.27
- Earnings Date
- Nov 5, 2026
- Pct From52w High
- -13.00%
- Pct From52w Low
- 112.79%